CBIS news out -- Cannabis Science, Inc. Finds Large-Scale Manufacturing and Product Distribution Facility in California and Eyes Nevada Property as Nevada Governor Issues Statement of Emergency Due to Potential Shortage of Cannabis
IRVINE, CA--(Marketwired - Jul 17, 2017) - Cannabis Science, Inc. ( OTC PINK : CBIS ), a U.S. company specializing in the development of cannabinoid-based medicines, has found a California facility ideal for its large-scale manufacturing and product distribution center as it ramps up its efforts to supply cannabinoid medications in high-demand by self-medicating patients. As Nevada's Governor issues a Statement of Emergency due to the potential of limited cannabis availability, CBIS is actively looking for a similar facility in Nevada.
"We have found a perfect space for our initial, large-scale manufacturing and product distribution in California," stated Mr. Raymond C. Dabney, CBIS' President, CEO, and Co-founder. "We also have impeccable partners to assist in our rapidly moving, high-growth schedule. We now have access to the required machinery and expertise to begin the in-house manufacturing process." CBIS' experts will oversee operations to ensure that the Company's established protocols are flawlessly replicated. This type of manufacturing and distribution facility allows CBIS to distribute its products to patients faster, in much larger volumes, and in a very cost-effective manner. Being its own manufacturer and producer of the raw materials required for its manufacturing processes, CBIS will ensure that cost-effective standards are applied to the production of its current products, including pills, extracts, creams, tinctures, and sprays. CBIS' quality assurance program will also be applied to the development and distribution of new and exciting products that can be developed and released on demand for self-medicating patients.
A new opportunity has appeared and CBIS believes that this augers well for the future. Nevada's governor has endorsed a Statement of Emergency declared for marijuana regulations, after the state's tax authority declared that many stores are running out of marijuana and cannabinoid products. The Nevada Tax Commission said in a statement that it will consider emergency regulations to provide a structure for marijuana distribution to retailers. Based on reports of adult-use, marijuana sales have already far exceeded the industry's expectations at the state's 47 licensed retail marijuana dispensaries. Given that many stores are running out of inventory, the Department must address the lack of distributors immediately.
"We have considerable land holdings in Nevada through our partnerships and we see this as an outstanding opportunity for us to speed up our cultivation efforts in Nevada. This huge demand will help us achieve our goals of becoming a large-scale producer in Nevada. This supply concern should help accelerate our approvals for licensing and help us begin new product sales in Nevada in the very near future," concluded Mr. Dabney.
IRVINE, CA--(Marketwired - Jul 17, 2017) - Cannabis Science, Inc. ( OTC PINK : CBIS ), a U.S. company specializing in the development of cannabinoid-based medicines, has found a California facility ideal for its large-scale manufacturing and product distribution center as it ramps up its efforts to supply cannabinoid medications in high-demand by self-medicating patients. As Nevada's Governor issues a Statement of Emergency due to the potential of limited cannabis availability, CBIS is actively looking for a similar facility in Nevada.
"We have found a perfect space for our initial, large-scale manufacturing and product distribution in California," stated Mr. Raymond C. Dabney, CBIS' President, CEO, and Co-founder. "We also have impeccable partners to assist in our rapidly moving, high-growth schedule. We now have access to the required machinery and expertise to begin the in-house manufacturing process." CBIS' experts will oversee operations to ensure that the Company's established protocols are flawlessly replicated. This type of manufacturing and distribution facility allows CBIS to distribute its products to patients faster, in much larger volumes, and in a very cost-effective manner. Being its own manufacturer and producer of the raw materials required for its manufacturing processes, CBIS will ensure that cost-effective standards are applied to the production of its current products, including pills, extracts, creams, tinctures, and sprays. CBIS' quality assurance program will also be applied to the development and distribution of new and exciting products that can be developed and released on demand for self-medicating patients.
A new opportunity has appeared and CBIS believes that this augers well for the future. Nevada's governor has endorsed a Statement of Emergency declared for marijuana regulations, after the state's tax authority declared that many stores are running out of marijuana and cannabinoid products. The Nevada Tax Commission said in a statement that it will consider emergency regulations to provide a structure for marijuana distribution to retailers. Based on reports of adult-use, marijuana sales have already far exceeded the industry's expectations at the state's 47 licensed retail marijuana dispensaries. Given that many stores are running out of inventory, the Department must address the lack of distributors immediately.
"We have considerable land holdings in Nevada through our partnerships and we see this as an outstanding opportunity for us to speed up our cultivation efforts in Nevada. This huge demand will help us achieve our goals of becoming a large-scale producer in Nevada. This supply concern should help accelerate our approvals for licensing and help us begin new product sales in Nevada in the very near future," concluded Mr. Dabney.
